Status:
COMPLETED
Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Lung Non-Small Cell Carcinoma
Lung Small Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies the effect of a form of cognitive-behavioral therapy, Take a Breath, on reducing the intensity and frequency of dyspnea (difficulty breathing) in patients with lung cancer. Take a B...
Detailed Description
PRIMARY OBJECTIVE: I. To determine the acceptability (based on patient satisfaction), tolerability (based on rate of symptom exacerbation from pre- to post-treatment), and feasibility (based on numbe...
Eligibility Criteria
Inclusion
- Diagnosed with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC)
- Currently experiencing dyspnea as defined by a score \>= 1 on the American Thoracic Society (ATS) Dyspnea Questionnaire within 3 weeks of enrollment
- Seeking medical oncology care and treatment at the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic
- Ability to understand and willingness to sign an informed consent document
Exclusion
- Presence of other serious comorbidities that would interfere with patients' study participation (e.g., serious mental illness, heart disease) as determined by the treating oncologist
- Life expectancy \< 2 months
- History of surgery for lung cancer
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05304793
Start Date
July 1 2020
End Date
July 16 2021
Last Update
October 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210